The Liver Meeting® offers a variety of continuing education options – from Certificates of Attendance to Maintenance of Certification points. View our full list of programming to plan which sessions you will be attending this year.
Information on statements and the types of continuing education options AASLD is offering can be found on the Continuing Education Statement tab below.
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statements
The American Association for the Study of Liver Diseases (AASLD) designates this other activity (internet live course and internet enduring material) for a maximum of 78 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: Select sessions may not be eligible for CME credit, and will be noted accordingly.
American Board of Internal Medicine (ABIM) MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 78 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please note: Select sessions may not be eligible for CME/MOC credit and will be noted accordingly.
Continuing Education (CE) Statement
Satisfactory completion: Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the American Association for the Study of Liver Diseases. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit Designation Statement – Live Content – Amedco LLC designates the live activity portion for a maximum of 5.00 ANCC contact hours for nurses.
Credit Designation Statement – Enduring Content – Amedco LLC designates the enduring material activity portion for a maximum of 12.5 ANCC contact hours for nurses.
Learners should claim only the credit commensurate with the extent of their participation in the activities. The 2.50 live hours that were recorded cannot also be claimed as enduring hours.
Nurse Pharmacology Credits
Please note the agenda for identification of sessions eligible for pharmacotherapeutic hours and self-submit those to your board. Keep the agenda as a reference in case they have questions. Maximum of 7.00 hours.
Chronic liver disease and cirrhosis are among the 15 leading causes of death in the United States. TLMdX will facilitate the exchange of scientific knowledge from cutting-edge clinical, basic and translational research in liver transplantation and diseases of the liver and biliary tract. Integrating evidence-based medicine and new quality concepts into practice is essential to ultimately improve health outcomes. Through networking opportunities and a variety of educational and interactive sessions, health care professionals worldwide can effectively diagnose and manage liver disorders.
All health care providers with an interest in hepatology will benefit from the information presented at TLMdX including:
- Hepatologists (Adult and Pediatric)
- Transplant Hepatologists (Adult and Pediatric)
- Gastroenterologists (Adult and Pediatric)
- Nurse Practitioners
- Physician Assistants
- Transplant Coordinators
- Internal Medicine Physicians
- Internal Medicine Residents and Medical Students
- Cell Biologists
- Lawyers who specialize in medical practice
- Infectious Disease Specialists
- Public Health Workers
- Research Coordinators
- Nurse Educators
- Pharmaceutical Industry Representatives
- Patient Advocates/ Patient Advocacy Group Representatives
Upon completion of this live activity, learners will be able to:
- Evaluate recent advancements in groundbreaking basic, translational, comparative effectiveness, outcomes and clinical research in diseases of the liver and biliary tract that may be readily incorporated into practice.
- Examine short- and long-term patient outcomes following liver transplantation by integrating current evidence-based practice in pre-transplant clinical care, advances in surgical techniques and state-of-the-art postoperative management.
- Formulate partnerships and develop comparative effectiveness projects, design clinical trials and complete ongoing investigative efforts to improve the health outcomes in acute and chronic diseases of the liver and biliary tract.
The Liver Meeting Digital Experience™ was planned in the context of the following ACGME/IOM/IPEC competencies:
- Patient Care and Procedural Skills
- Medical Knowledge
- Practice-based Learning and Improvement
- Interpersonal and Communication Skills
- Systems-based Practice
- Provide Patient-centered Care
- Work in Interdisciplinary Teams
- Employ Evidence-based Practice
- Apply Quality Improvements
- Utilize Informatics
- Values/Ethics for Interprofessional Practice
- Interprofessional Communication
- Teams and Teamwork